Midnight is a sativa dominant hybrid that balances a near 1:1 ratio of THC and CBD. Earning its name from its distinctive purple leaves, Midnight represents a great option for new and seasoned users alike. Moderate levels of cannabinoids produce minimal side effects while still providing all the benefits of THC & CBD, offering clear-headed, functional pain relief. Named Top Hybrid Flower at the 2017 Canadian Cannabis awards, this strain helps treat fibromyalgia, tinnitus, Parkinson’s Disease, and nausea.
Cannabis is often used by patients with ulcerative colitis, but controlled studies are few. We aimed to assess the effect of cannabis in improving clinical and inflammatory outcomes in ulcerative colitis patients.